The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Hospitals across the country are now facing a shortage of the Bacille Calmette-Guérin (BCG) vaccine, which protects newborns ...

A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...

A nationwide shortage of BCG vaccines in the country leaves Kenyan newborns vulnerable to TB, a disease with a high ...

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

The in-built in protection mechanisms offer a safer and more effective way to combat the deadliest disease of 2024.

In cancer treatment, bacterial vaccines are used to enhance the body's immune response against tumour cells. For instance, in early-stage bladder cancer, Bacillus Calmetteâ Guérin (BCG ...

Best known for its role in tuberculosis prevention, the BCG vaccine is based on a harmless strain of bacteria related the one that causes tuberculosis. A generic drug with over 100 years of ...

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of Pittsburgh research published ...

the BCG vaccine can prepare the bone marrow for an emergency response in case of a body-wide infection that’s not necessarily tuberculosis. If bacteria or viruses attack, such vaccine-prepped ...

BCG, she explains acts as an antigen, teaching the body’s immune system to recognise and combat TB bacteria without causing infection. "BCG vaccine is a very important vaccine. An infant who is ...